Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is an aggressive tumor with a high mortality rate because of the limited systemic and locoregional treatment modalities. The development and progression of HCC depend on epigenetic changes that result in the activation or...
Saved in:
| Main Authors: | Mengnan Guo, Ning Li, Jianxia Zheng, Wei Wang, Yan Wu, Xu Han, Jiapei Guo, Weixi Chen, Zekun Bai, Wen Bai, Jinghua Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2021/5596712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways
by: Li Chen, et al.
Published: (2025-03-01) -
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products
by: Chen G, et al.
Published: (2024-12-01) -
circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway
by: Chunchen Wu, et al.
Published: (2022-01-01) -
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01) -
Targeting the mTOR pathway in breast cancer
by: Jia Liu, et al.
Published: (2017-06-01)